Inventor · disambiguated record
Jeroen Cunera Verheijen
Also filed as: VERHEIJEN JEROEN · VERHEIJEN JEROEN C · VERHEIJEN JEROEN CUNERA
15 granted patents·9 pending applications·95 citations·filing 2004–2018
93Inventor score
Files withWYETH CORP6WYETH LLC5ENTASIS THERAPEUTICS LTD3COLUCID PHARMACEUTICALS INC2VENKATESAN ARANAPAKAM MUDUMBAI2
Top patents by PatentIndex Score
24 records- 0192US8039469B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2009·Granted Oct 18, 2011·15 cites·17 claims
- 0291US10022381B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2015·Granted Jul 17, 2018·5 cites·6 claims
- 0391US8748421B2Triazine compounds as P13 kinase and MTOR inhibitorsWYETH LLC·Filed 2013·Granted Jun 10, 2014·11 cites·9 claims
- 0489US8859542B2Triazine compounds as PI3 kinase and mTOR inhibitorsWYETH LLC·Filed 2014·Granted Oct 14, 2014·9 cites·12 claims
- 0589US8575159B2Triazine compounds as PI3 kinase and mTOR inhibitorsPFIZER·Filed 2012·Granted Nov 5, 2013·9 cites·21 claims
- 0689US8217036B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2011·Granted Jul 10, 2012·12 cites·10 claims
- 0785US9174963B2Triazine compounds as PI3 kinase and MTOR inhibitorsWYETH LLC·Filed 2014·Granted Nov 3, 2015·5 cites·2 claims
- 0884US8445486B2Triazine compounds as PI3 kinase and mTOR inhibitorsVENKATESAN ARANAPAKAM MUDUMBAI·Filed 2012·Granted May 21, 2013·5 cites·10 claims
- 0983US10800778B2Beta-lactamase inhibitor compoundsENTASIS THERAPEUTICS LTD·Filed 2017·Granted Oct 13, 2020·4 cites·25 claims
- 1083US8129371B2Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitorsZASK ARIE·Filed 2008·Granted Mar 6, 2012·11 cites·46 claims
- 1181US9968593B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2015·Granted May 15, 2018·4 cites·8 claims
- 1280US10376499B2Combination therapy for treatment of resistant bacterial infectionsENTASIS THERAPEUTICS LTD·Filed 2018·Granted Aug 13, 2019·3 cites·9 claims
- 1371US2010010097A1Methods for treating mild cognitive impairment and alzheimer's diseaseCOGNITION PHARMACEUTICALS LLC·Filed 2008·Application pending·0 cites
- 1462US7897639B2Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agentsCOLUCID PHARMACEUTICALS INC·Filed 2004·Granted Mar 1, 2011·2 cites·15 claims
- 1558US2005059743A1Methods for treating mild cognitive impairment and alzheimer's diseaseSENTION INC·Filed 2004·Application pending·0 cites
- 1655US2009192176A11H-PYRAZOLO[3,4-D]PYRIMIDINE, PURINE, 7H-PURIN-8(9H)-ONE, 3H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE, AND THIENO[3,2-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 1755US2010003250A1(2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesesWYETH CORP·Filed 2009·Application pending·0 cites
- 1853US7795307B2Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agentsCOLUCID PHARMACEUTICALS INC·Filed 2004·Granted Sep 14, 2010·0 cites·11 claims
- 1951US2009181963A13H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE COMPOUNDS, THEIR USE AS mTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESESWYETH CORP·Filed 2009·Application pending·0 cites
- 2049US2009149458A1PYRROLO[3,2-d]PYRIMIDINE COMPOUNDS AND THEIR USE AS PI3 KINASE AND mTOR KINASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 2148US2008234262A1Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 2247US2008233127A1Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitorsWYETH CORP·Filed 2008·Application pending·0 cites
- 2345US2011144177A1Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active AgentsVERHEIJEN JEROEN C·Filed 2011·Application pending·0 cites
- 2429US8835429B2Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their synthesesCURRAN KEVIN JOSEPH·Filed 2010·Granted Sep 16, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →